| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
Ibnsina Pharma Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ج.م2.97 |
| 52 Week High | ج.م4.15 |
| 52 Week Low | ج.م1.78 |
| Beta | 0.30 |
| 11 Month Change | 5.32% |
| 3 Month Change | 15.12% |
| 1 Year Change | 36.24% |
| 33 Year Change | -9.77% |
| 5 Year Change | -60.73% |
| Change since IPO | -31.54% |
Recent News & Updates
Recent updates
Shareholder Returns
| ISPH | EG Healthcare | EG Market | |
|---|---|---|---|
| 7D | -2.6% | -2.8% | 2.4% |
| 1Y | 36.2% | 40.7% | 62.0% |
Return vs Industry: ISPH underperformed the EG Healthcare industry which returned 40.7% over the past year.
Return vs Market: ISPH underperformed the EG Market which returned 62% over the past year.
Price Volatility
| ISPH volatility | |
|---|---|
| ISPH Average Weekly Movement | 6.6% |
| Healthcare Industry Average Movement | 5.7% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in EG Market | 9.0% |
| 10% least volatile stocks in EG Market | 3.3% |
Stable Share Price: ISPH has not had significant price volatility in the past 3 months.
Volatility Over Time: ISPH's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | n/a | Mohamed Mohsen Mahgoub | www.ibnsina-pharma.com |
Ibnsina Pharma operates as a pharmaceutical distributor in Egypt. The company offers pharmaceutical and cosmetics products to private and public-sector customers, including retail chains, independent pharmacies, wholesalers, and hospitals and healthcare institutions. It also provides warehousing and logistic services for its suppliers; marketing solutions; importation and packaging services; and market research and analysis services.
Ibnsina Pharma Fundamentals Summary
| ISPH fundamental statistics | |
|---|---|
| Market cap | ج.م2.99b |
| Earnings (TTM) | ج.م194.94m |
| Revenue (TTM) | ج.م37.68b |
15.4x
P/E Ratio0.1x
P/S RatioIs ISPH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ISPH income statement (TTM) | |
|---|---|
| Revenue | ج.م37.68b |
| Cost of Revenue | ج.م34.93b |
| Gross Profit | ج.م2.75b |
| Other Expenses | ج.م2.55b |
| Earnings | ج.م194.94m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.19 |
| Gross Margin | 7.29% |
| Net Profit Margin | 0.52% |
| Debt/Equity Ratio | 841.3% |
How did ISPH perform over the long term?
See historical performance and comparison